Role of VIP and PACAP in islet function.

Peptides

Department of Clinical Sciences, Division of Medicine, Lund University, BMC, B11, SE-221 84 Lund, Sweden.

Published: September 2007

Vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) are two closely related neuropeptides that are expressed in islets and in islet parasympathetic nerves. Both peptides bind to their common G-protein-coupled receptors, VPAC1 and VPAC2, and PACAP, in addition to the specific receptor PAC1, all three of which are expressed in islets. VIP and PACAP stimulate insulin secretion in a glucose-dependent manner and they both also stimulate glucagon secretion. This action is achieved through increased formation of cAMP after activation of adenylate cyclase and stimulation of extracellular calcium uptake. Deletion of PAC1 receptors or VPAC2 receptors results in glucose intolerance. These peptides may be of importance in mediating prandial insulin secretion and the glucagon response to hypoglycemia. Animal studies have also suggested that activation of the receptors, in particular VPAC2 receptors, may be used as a therapeutic approach for the treatment of type 2 diabetes. This review summarizes the current knowledge of the potential role of VIP and PACAP in islet function.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.peptides.2007.04.024DOI Listing

Publication Analysis

Top Keywords

vip pacap
12
role vip
8
pacap islet
8
islet function
8
expressed islets
8
insulin secretion
8
receptors vpac2
8
vpac2 receptors
8
pacap
5
receptors
5

Similar Publications

The defense mechanisms of the vertebrate brain against infections are at the forefront of immunological studies. Unlike other body parts, the brain not only fends off pathogenic infections but also minimizes the risk of self-damage from immune cell induced inflammation. Some neuropeptides produced by either nerve or immune cells share remarkable similarities with antimicrobial peptides (AMPs) in terms of size, structure, amino acid composition, amphiphilicity, and net cationic charge.

View Article and Find Full Text PDF

Estrogens impair hypophagia and hypothalamic cell activation induced by vasoactive intestinal peptide, but not by pituitary adenylate cyclase-activating polypeptide.

Peptides

January 2025

Programa Multicêntrico de Pós-Graduação em Ciências Fisiológicas, Universidade Estadual de Londrina, Londrina, PR, Brazil; Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Estadual de Londrina, Londrina, PR, Brazil; Laboratório de Fisiologia Neuroendócrina e Metabolismo, Departamento de Ciências Fisiológicas, Universidade Estadual de Londrina, Londrina, PR, Brazil. Electronic address:

Article Synopsis
  • The study investigated how estradiol affects food intake and receptor expression in postmenopausal rats, particularly looking at the neuropeptides VIP and PACAP in specific hypothalamic areas.
  • Results showed that estradiol reduced the expression of the VPAC2 receptor and disrupted the hypophagic (appetite-reducing) effects of VIP, while PACAP continued to suppress food intake.
  • Additionally, estradiol altered plasma glucose and free fatty acid levels in these rats, suggesting different mechanisms in how VIP and PACAP influence energy homeostasis in the context of estrogen loss.
View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the relationship between post-traumatic stress disorder (PTSD) and migraines, focusing on its prevalence in patients with episodic migraines (EM) and chronic migraines (CM).
  • The research involved 116 patients, finding that PTSD was more common in those with chronic migraines, and it significantly affected their quality of life and comorbidities like anxiety and depression.
  • The findings highlight the need for further studies to explore the impact of PTSD on migraines, particularly in cases linked to traumatic life events such as sexual violence.
View Article and Find Full Text PDF
Article Synopsis
  • BDNF plays an important role in brain function and may help with pain and depression; this study tested its effectiveness against migraines using an animal model.
  • Researchers administered two doses of recombinant human BDNF (rhBDNF) to rats with pain induced by NTG injections, measuring pain response and changes in brain-related neuropeptides and cytokine levels.
  • Results showed that rhBDNF significantly reduced migraine-related pain and altered gene expression similarly to the migraine medication sumatriptan, indicating its potential as a non-invasive migraine treatment.
View Article and Find Full Text PDF

Inflammation with expression of interleukin 6 (IL-6) in the central nervous system (CNS) occurs in several neurodegenerative/neuroinflammatory conditions and may cause neurochemical changes to endogenous neuroprotective systems. Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) are two neuropeptides with well-established protective and anti-inflammatory properties. Yet, whether PACAP and VIP levels are altered in mice with CNS-restricted, astrocyte-targeted production of IL-6 (GFAP-IL6) remains unknown.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!